Genetic Technologies kicks off US breast cancer imaging campaign

The Market Herald04-11

Dual ASX and NASDAQ smallcap Genetic Technologies (ASX:GTG) has announced its launch of a breast cancer imaging program across three US clinics in NY, Miami and Houston, Texas. The program will ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2426140466?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-04-11 12:27","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2426140466","market":"hk","top_or_hot":-1,"title":"Genetic Technologies kicks off US breast cancer imaging campaign","media":"The Market Herald","content":"<div>\n<p>Dual ASX and NASDAQ smallcap Genetic Technologies (ASX:GTG) has announced its launch of a breast cancer imaging program across three US clinics in NY, Miami and Houston, Texas.\nThe program will ...</p>\n\n<a href=\"https://themarketonline.com.au/genetic-technologies-kicks-off-us-breast-cancer-imaging-campaign-2024-04-11/\">Source Link</a>\n\n</div>\n","source":"markerherald_stock","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Genetic Technologies kicks off US breast cancer imaging campaign</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGenetic Technologies kicks off US breast cancer imaging campaign\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-04-11 12:27 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://themarketonline.com.au/genetic-technologies-kicks-off-us-breast-cancer-imaging-campaign-2024-04-11/><strong>The Market Herald</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Dual ASX and NASDAQ smallcap Genetic Technologies (ASX:GTG) has announced its launch of a breast cancer imaging program across three US clinics in NY, Miami and Houston, Texas.\nThe program will ...</p>\n\n<a href=\"https://themarketonline.com.au/genetic-technologies-kicks-off-us-breast-cancer-imaging-campaign-2024-04-11/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK7048","symbol_name":"生命科学工具和服务","start_time":0,"source_url":"https://themarketonline.com.au/genetic-technologies-kicks-off-us-breast-cancer-imaging-campaign-2024-04-11/","article_id":"2426140466","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2426140466","pubTimestamp":1712809620,"sourceInfo":{"source_id":"markerherald_stock","name":"The Market Herald"},"weMediaInfo":null,"summary":"Dual ASX and NASDAQ smallcap Genetic Technologies  has announced its launch of a breast cancer imaging program across three US clinics in NY, Miami and Houston, Texas.The program will integrate GTG’s “geneType” saliva-based and software-informed genomics prediction product – which it says can assess patient-by-patient genomic background datum to assess the probability risks that one may or may not develop cancer.In the case of the program launched on Thursday, this will specifically address breast cancer, though, the company does offer similar products to men.By using the company’s ‘geneType Breast Cancer Risk Assessment Test’ at imaging centres, the company believes “patients at higher risk of breast cancer can be easily identified during imaging appointments.”All in all, the company’s tech is intended to fast-track those patients most at risk into triage. Part of this ability is due to the company’s inclusion of breast density data, according to GTG.The company is also banking on cus","collect":0,"end_time":0,"defaultTopTitle":"themarketonline.com.au","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK7048":"生命科学工具和服务","QID":"纳指两倍做空ETF","QLD":"纳指两倍做多ETF","QQQ":"纳指100ETF","BK4121":"生命科学工具和服务","SQQQ":"纳指三倍做空ETF","PSQ":"纳指反向ETF","BK7508":"医药生物股","GENE":"基因技术ADR","TQQQ":"纳指三倍做多ETF",".IXIC":"NASDAQ Composite","GTG.AU":"Genetic Technologies Ltd"},"translate_title":"基因技术启动美国乳腺癌成像运动","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"GENE":1,"GTG.AU":1,".IXIC":0.9,"MNQmain":0.6,"NQmain":0.6,"PSQ":0.6,"QID":0.6,"QLD":0.6,"QQQ":0.6,"SQQQ":0.6,"TQQQ":0.6},"content_text":"Dual ASX and NASDAQ smallcap Genetic Technologies (ASX:GTG) has announced its launch of a breast cancer imaging program across three US clinics in NY, Miami and Houston, Texas.\nThe program will integrate GTG’s “geneType” saliva-based and software-informed genomics prediction product – which it says can assess patient-by-patient genomic background datum to assess the probability risks that one may or may not develop cancer.\nIn the case of the program launched on Thursday, this will specifically address breast cancer, though, the company does offer similar products to men. \nBy using the company’s ‘geneType Breast Cancer Risk Assessment Test’ at imaging centres, the company believes “patients at higher risk of breast cancer can be easily identified during imaging appointments.”\nAll in all, the company’s tech is intended to fast-track those patients most at risk into triage. Part of this ability is due to the company’s inclusion of breast density data, according to GTG. \nThe company is also banking on customised patient data spurring enthusiasm for patient recipients, thus making them” more likely to adhere to recommended screening protocols,” according to GTG.\nThe company noted on Thursday that US breast cancer screening is predominately focused on women between the ages of 40 and 74, an addressable market of 68M individuals.\nAll this said, for a company on the NASDAQ, Genetic Technologies is relatively thinly traded down under. \nIts shares were down nearly -8.6% in early lunchtime trades on Thursday following its announcement, based on some $54K worth of trading volume turnover. Compare that to leading financial stock CBA, whose trading volume turnover reflected $85M at the same time of day. \nInterestingly, GTG’s market cap on the ASX is technically larger than that on the NASDAQ – A$18M down under vs. US$10M on the NASDAQ. \nOne HotCopper user on Thursday mused over how, exactly, this company receives so little attention – a stock that at one point also had some airtime on Channel 7’s nighttime programming. \nGTG shares last traded at 16cps.","kind":null,"is_publish_news":null,"is_publish_highlight":null,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2426140466"}